452 5th Avenue
New York , NY 10018
New York , NY 10018
Executive/
Director
Links
Price
- Last Close
-
$ 12.86
$ +0.34 2.72 %
Aug 29, 2024
- 52-Week High/Low
- $26.89 - $10.5
- YTD
- -48.2%
- Trading Volume
- 616,124
- Market Cap Full
- $ 7.2B
- Shares Outstanding
-
557.9M
Apr 30, 2023
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Q1 | - | - | - | - | - | - | - | -50.8% | 38.2% | -8.8% |
Q2 | - | - | - | - | - | - | -1.6% | -15.7% | -5.7% | -2.8% |
Q3 | - | - | - | - | - | - | -22.6% | -30.7% | 3.4% | - |
Q4 | - | - | - | - | - | - | -16.6% | 0.8% | 44.2% | - |
J | F | M | A | M | J | J | A | S | O | N | D | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -7.5% | 3.1% | -4.4% | -4.9% | - | - | - | - | - | - | - | - |
2023 | 20.8% | -3.4% | 18.4% | -19.8% | 27% | -7.5% | 9.2% | -12.6% | 8.4% | -9.3% | 27.2% | 25.8% |
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -71% | 96% | -48% |
Earnings
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Q1 | - | - | 0.19 | 0.37 | -0.05 |
Q2 | - | - | -1.11 | -0.23 | -0.06 |
Q3 | - | - | -0.19 | -0.22 | -0.11 |
Q4 | - | - | -0.23 | -0.10 | -0.06 |
A | -3.4 | -0.6 | -1.2 | -0.6 | -0.28 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Mar | 152.4 | 168.3 | 454.6 | 548 |
Jun | - | 215.4 | 541.9 | 557.9 |
Sep | 162.9 | 526.5 | 546.1 | - |
Dec | 171.3 | 531.7 | 550.2 | - |
SEC Filings
Financial Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Asset Management | ||||
Inventory / Stock Turnover | - | - | - | - |
Fixed Asset Turnover | 13.7 | 16.9 | - | - |
Total Asset Turnover | 0.4 | 0.7 | - | - |
Leverage | ||||
Debt Ratio | - | - | - | - |
Debt – Equity Ratio | - | - | - | - |
Interest Coverage | -20 | 6.1 | -172.3 | - |
Equity multiplier | - | - | - | - |